X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26) 26
female (22) 22
index medicus (21) 21
breast cancer (19) 19
cancer (16) 16
chemotherapy (15) 15
oncology (15) 15
breast neoplasms - pathology (12) 12
middle aged (11) 11
adult (10) 10
pathology (10) 10
prognosis (10) 10
biomarkers, tumor - analysis (9) 9
breast neoplasms - drug therapy (9) 9
aged (8) 8
algorithms (8) 8
article (7) 7
cancer therapies (7) 7
tamoxifen (7) 7
chemotherapy, adjuvant (6) 6
cyclophosphamide (6) 6
trastuzumab (6) 6
trial (6) 6
tumors (6) 6
women (6) 6
adjuvant treatment (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
biomarkers (5) 5
breast neoplasms - genetics (5) 5
care and treatment (5) 5
colon-cancer (5) 5
diagnosis (5) 5
gene expression (5) 5
medicine & public health (5) 5
medicine, general & internal (5) 5
neoplasm staging (5) 5
research (5) 5
survival analysis (5) 5
therapy (5) 5
treatment outcome (5) 5
analysis (4) 4
biomarkers, tumor (4) 4
breast neoplasms - metabolism (4) 4
clinical trials (4) 4
doxorubicin (4) 4
gene expression profiling (4) 4
immunohistochemistry (4) 4
immunohistochemistry - methods (4) 4
immunotherapy (4) 4
lymphocytes (4) 4
mastectomy (4) 4
medical laboratory technology (4) 4
medical prognosis (4) 4
medicine, research & experimental (4) 4
metastasis (4) 4
paclitaxel (4) 4
patients (4) 4
predictive value of tests (4) 4
reproducibility of results (4) 4
surgery (4) 4
surgical adjuvant breast (4) 4
survival (4) 4
tumor-infiltrating (4) 4
abridged index medicus (3) 3
animals (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
biopsy (3) 3
breast neoplasms - mortality (3) 3
breast neoplasms - surgery (3) 3
clinical trials as topic (3) 3
colorectal-cancer (3) 3
disease-free survival (3) 3
drug therapy (3) 3
follow-up studies (3) 3
gene-expression (3) 3
genes, erbb-2 (3) 3
hematology, oncology and palliative medicine (3) 3
her-2/neu gene amplification (3) 3
her2 (3) 3
male (3) 3
neoplasm invasiveness (3) 3
oncology, experimental (3) 3
preoperative chemotherapy (3) 3
randomized-trial (3) 3
receptors, estrogen - metabolism (3) 3
recurrence (3) 3
risk (3) 3
studies (3) 3
tamoxifen - therapeutic use (3) 3
trial comparing doxorubicin (3) 3
united states (3) 3
usage (3) 3
validation (3) 3
acquired-resistance (2) 2
adjuvant (2) 2
adjuvant chemotherapy (2) 2
aged, 80 and over (2) 2
angiogenesis (2) 2
anthracyclines (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9938, pp. 164 - 172
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 12, pp. 1183 - 1192
Summary Background We studied the effect on tumour response to neoadjuvant therapy of the substitution of lapatinib for trastuzumab in combination with weekly... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | WOMEN | CELLS | SURGICAL ADJUVANT BREAST | PREOPERATIVE CHEMOTHERAPY | ONCOLOGY | GW572016 | CHEMOTHERAPY PLUS TRASTUZUMAB | PERTUZUMAB | INHIBITOR | DOCETAXEL | Breast Neoplasms - surgery | Cyclophosphamide - administration & dosage | Puerto Rico | United States | Humans | Receptor, ErbB-2 - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Breast Neoplasms - enzymology | Antibodies, Monoclonal, Humanized - administration & dosage | Time Factors | Biomarkers, Tumor - metabolism | Mastectomy | Female | Neoadjuvant Therapy | Quinazolines - administration & dosage | Receptor, ErbB-2 - antagonists & inhibitors | Chemotherapy, Adjuvant | Biomarkers, Tumor - antagonists & inhibitors | Odds Ratio | Paclitaxel - administration & dosage | Doxorubicin - administration & dosage | Drug Administration Schedule | Logistic Models | Treatment Outcome | Chi-Square Distribution | Breast Neoplasms - drug therapy | Canada | Protein Kinase Inhibitors - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Intention to Treat Analysis | Quinazolines - adverse effects | Trastuzumab | Health maintenance organizations | Neoadjuvant therapy | Medical colleges | Care and treatment | Cyclophosphamide | Anthracyclines | Adjuvant treatment | Breast cancer | Product development | Public health | Cancer | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 9, pp. 1037 - 1048
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2006, Volume 25, Issue 1, pp. 118 - 145
Journal Article
The Lancet, ISSN 0140-6736, 12/2019, Volume 394, Issue 10215, pp. 2155 - 2164
Journal Article
Archives of Pathology and Laboratory Medicine, ISSN 0003-9985, 06/2010, Volume 134, Issue 6, pp. 907 - 922
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2004, Volume 351, Issue 27, pp. 2817 - 2826
Journal Article